Anticandidal and Antibiofilm Effect of Synbiotics including Probiotics and Inulin-Type Fructans.

2022-08-21
Antibiotics (Basel, Switzerland) 11(8)

PubMed: 36010004
DOI: 10.3390/antibiotics11081135

Study Design

Population: clinically isolated Candida albicans strain
Methods: growth inhibition was evaluated using microdilution analysis in 96-well microtiter plates; different concentrations of cell-free supernatants of Lacticaseibacillus rhamnosus and Pediococcus acidilactici were exposed to Candida albicans; antibiofilm assessment was carried out using the crystal violet staining assay; short-chain fatty acids were analyzed by gas chromatography

Background

There is great interest in the search for new alternatives to antimicrobial drugs, and the use of synbiotics is a promising approach to this problem. This study evaluated the growth inhibition and antibiofilm activity of the short-chain fatty acids produced by Lacticaseibacillus rhamnosus and Pediococcus acidilactici in combination with inulin-type fructans against Candida albicans.

Methods

The growth inhibition of Candida was evaluated using microdilution analysis in 96-well microtiter plates; different concentrations of cell-free supernatants of Lacticaseibacillus rhamnosus and Pediococcus acidilactici were exposed to Candida albicans. The antibiofilm assessment was carried out using the crystal violet staining assay. The short-chain fatty acids were analyzed by gas chromatography.

Results

The clinically isolated Candida albicans interacted with supernatants from Lacticaseibacillus rhamnosus and Pediococcus acidilactici and showed significant growth inhibition and antibiofilm formation versus the controls. Lactate and acetic acid were elevated in the supernatants. The results suggest that the supernatants obtained from the synbiotic combinations of Lacticaseibacillus rhamnosus and Pediococcus acidilactici with inulin-type fructans can inhibit the growth and biofilm formation against a clinically isolated Candida albicans strain.

Conclusions

These results suggest that synbiotic formulations could be a promising alternative to antifungal drugs in candidiasis therapy.

Research Insights

Supplement	Dose	Health Outcome	Effect Type	Effect Size	Source
Lactobacillus rhamnosus NH001	—	Reduced Candida albicans Growth	Beneficial	Moderate	View source The clinically isolated Candida albicans interacted with supernatants from Lacticaseibacillus rhamnosus and Pediococcus acidilactici and showed significant growth inhibition